🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
NODE-202 is a Phase 2, multicenter, multinational, single dose, open-label,...
Status
Recruiting
Location
Phoenix Children's Hospital
Start Date
2023-12-11
Trial ID
NCT05763953
Treatments Being Tested
This is a multi-national, multi-center, randomized, double-blind, placebo-c...
Status
Not Yet Recruiting
Location
Cardiovascular Associates Of The Delaware Valley
Start Date
2027-01
Trial ID
NCT06716021
To determine whether etripamil nasal spray (NS) self-administered by Chines...
Status
Completed
Location
Baotou Central Hospital
Start Date
2022-06-30
Trial ID
NCT05410860
Treatments Being Tested
The objectives of the study are as below: Primary: ·To evaluate the pharm...
Status
Completed
Location
Huashan Hospital Affiliated to Fudan University
Start Date
2023-03-07
Trial ID
NCT05511870
Treatments Being Tested
The primary objective of this study is to evaluate the safety of etripamil ...
Status
Terminated
Location
Arizona Arrhythmia Research Center
Start Date
2018-12-10
Trial ID
NCT03635996
Treatments Being Tested
This Open Label Extension study will enable eligible patients with Paroxysm...
Status
Completed
Location
Site # 0160
Start Date
2021-12-13
Trial ID
NCT04952610
Treatments Being Tested
Many patients with atrial fibrillation (AF) experience persistent tachycard...
Status
Completed
Location
QEII HSC - Nova Scotia Health Authority
Start Date
2020-11-19
Trial ID
NCT04467905
NODE-303 was a multi-center, open label study to evaluate the safety of etr...
Status
Completed
Location
1077
Start Date
2019-09-23
Trial ID
NCT04072835
Treatments Being Tested